SamaCare Releases Benchmarks for Medical Benefit Prior Authorization Performance
SamaCare announced in a press release the launch of its Medical Benefit Prior Authorization Benchmarks, a dataset that offers visibility into approval rates and time to therapy for specialty medications. The dataset is based on real prior authorization activity from tens of thousands of specialty practices using SamaCare's platform.
The benchmarks provide quarterly insights into two key metrics that affect patient access to therapy: Net Approval Rate and Mean Time to Resolution. These measures track how payer policies are applied in practice and how quickly patients move from authorization to treatment.
In addition to the public benchmarks, SamaCare is offering life sciences organizations the option to generate custom Access Snapshots for individual therapies. These reports provide deeper insights into approval performance, time to therapy, and the main factors influencing access barriers.
The release arrives amid growing attention to prior authorization reform and transparency in healthcare administration.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Primary Partners Reports Lower Medicare Costs With Lightbeam Platform
Gemini Health Partners Launches AI Revenue Cycle Advisory Service
Medsender Launches Agentic Referral Management for Specialty Practices
MediSights Reports Study Using AI Agents for Myeloma Market Research
Zocdoc Launches Care Access Network for Appointment Booking
Daily AI Brief: the AI news that matters, in your inbox.